Title:The Roles of Alternative Splicing in Tumor-immune Cell Interactions
VOLUME: 20 ISSUE: 10
Author(s):Yue Wang, Honglei Zhang*, Baowei Jiao*, Jianyun Nie*, Xiyin Li, Wenhuan Wang and Hairui Wang
Affiliation:Third Affiliated Hospital of Kunming Medical University, Kunming 650118, State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, Third Affiliated Hospital of Kunming Medical University, Kunming 650118
Keywords:Alternative splicing, tumor cells, immune system, immunotherapy, neoantigens, Tumor specific-antigens (TSAs).
Abstract:Alternative splicing (AS) plays a significant role in the hallmarks of cancer and can provide
neoantigens for immunotherapy. Here, we summarize recent advances in immune system associated
tumor specific-antigens (TSAs) produced by AS. We further discuss the regulating mechanisms
involved in AS-mediated innate and adaptive immune responses and the anti-tumoral and protumoral
roles in different types of cancer. For example, ULBP1_RI, MLL5Δ21spe, NKp44-1Δ5,
MHC-IΔ7, CD200SΔ1, 2, PVR α/β/γ/δ and IL-33 variants 1/2/3 act as regulators in solid tumors and
IPAK4-L and, FOXP1ΔN100 exhibit functions in hematological cancers.
